Search Results - "Fleury, Aimee"

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function by Carter, Jeanne, Huang, Helen Q., Armer, Jane, Carlson, Jay W., Lockwood, Suzy, Nolte, Susan, Kauderer, James, Hutson, Alan, Walker, Joan L., Fleury, Aimee C., Bonebrake, Albert, Soper, John T., Mathews, Cara, Zivanovic, Oliver, Richards, William Edward, Tan, Annie, Alberts, David S., Barakat, Richard R., Wenzel, Lari B.

“…To assess quality of life (QOL) in patients who developed lower-extremity lymphedema (LLE) after radical gynecologic cancer surgery on prospective clinical…”
Get full text

A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study by Slomovitz, Brian M., Filiaci, Virginia L., Walker, Joan L., Taub, Michael C., Finkelstein, Karen A., Moroney, John W., Fleury, Aimee C., Muller, Carolyn Y., Holman, Laura L., Copeland, Larry J., Miller, David S., Coleman, Robert L.

“…Blocking the PI3K/AKT/mTOR pathway decreases resistance to hormonal therapy in endometrial carcinoma (EC). In this study, the aim was to assess the efficacy…”
Get full text

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE) by Carter, Jeanne, Huang, Helen Q., Armer, Jane, Carlson, Jay W., Lockwood, Suzy, Nolte, Susan, Stewart, Bob R., Kauderer, James, Hutson, Alan, Walker, Joan L., Fleury, Aimee C., Bonebrake, Albert, Soper, John T., Mathews, Cara, Zivanovic, Oliver, Richards, William Edwards, Tan, Annie, Alberts, David S., Barakat, Richard R., Wenzel, Lari

“…To explore whether patient-reported lymphedema-related symptoms, as measured by the Gynecologic Cancer Lymphedema Questionnaire (GCLQ), are associated with a…”
Get full text

Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study by Ahmed, Amina, Deng, Wei, Tew, William, Bender, David, Mannel, Robert S., Littell, Ramey D., DeNittis, Albert S., Edelson, Mitchell, Morgan, Mark, Carlson, Jay, Darus, Christopher J., Fleury, Aimee C., Modesitt, Susan, Olawaiye, Alexander, Evans, Anthony, Fleming, Gini F.

“…CC-002 is a prospective cooperative group study conducted by NRG Oncology to evaluate whether a pre-operative GA-GYN score derived from a predictive model…”
Get full text

Evaluation of exposures to healthcare personnel from cisplatin during a mock demonstration of intra-operative intraperitoneal chemotherapy administration by Kushnir, Christina L, Fleury, Aimee C, Couch, James, Hill, Michael C, Spirtos, Nick M

“…Abstract Ovarian cancer is the leading cause of death from gynecologic malignancies in the United States. In 2006, the National Cancer Institute released an…”
Get full text

The use of argon beam coagulation in treating vulvar intraepithelial neoplasia III: A retrospective review by Kushnir, Christina L, Fleury, Aimee C, Hill, Michael C, Silver, David F, Spirtos, Nick M

“…Abstract Argon beam coagulation (ABC) has unique properties which make it suitable for the local treatment of superficial epithelial disorders such as vulvar…”
Get full text

Primary uterine cancer in Maryland: impact of distance on access to surgical care at high-volume hospitals by Gunderson, Camille C, Tergas, Ana I, Fleury, Aimee C, Diaz-Montes, Teresa P, Giuntoli, 2nd, Robert L

“…To evaluate the influence of distance on access to high-volume surgical treatment for patients with uterine cancer in Maryland. The Maryland Health Services…”
Get more information

Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival by Giuntoli, 2nd, Robert L, Gerardi, Melissa A, Yemelyanova, Anna V, Ueda, Stefanie M, Fleury, Aimee C, Diaz-Montes, Teresa P, Bristow, Robert E

“…The aim of this study was to determine if comprehensive surgical staging is a better predictor of outcome than incomplete staging for women with stage I…”
Get more information

Post fellowship training in “new-to-them” surgical techniques: Assessment of learning curve characteristics by Miao, Jinwei, Fleury, Aimee C, Kushnir, Christina L, Silver, David F, Naik, Raj, Spirtos, Nick M

“…Abstract Objective To evaluate surgically related quality outcomes during the learning curve for board-certified or board-eligible gynecologic oncologists…”
Get full text

A preliminary exploration of conversation sampling in pediatric voice disorders by Reynolds, Victoria, Fleury, Aimee

“…Current methods of eliciting running speech for subjective rating, or perceptual analysis, in the assessment of pediatric voice disorders are not standardized…”
Get full text

Vocal health of sporting, fitness, and wellness leaders in Northern New York and Vermont by Gauvin, Nancy, Fleury, Aimee, Reynolds, Victoria

“…Fitness trainers and sporting coaches use their voices in acoustically poor conditions, for extended periods of time. Knowledge of the risk of voice problems…”
Get full text

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients by Carlson, Jay W., Kauderer, James, Hutson, Alan, Carter, Jeanne, Armer, Jane, Lockwood, Suzy, Nolte, Susan, Stewart, Bob R., Wenzel, Lari, Walker, Joan, Fleury, Aimee, Bonebrake, Albert, Soper, John, Mathews, Cara, Zivanovic, Oliver, Richards, Wm Edward, Tan, Annie, Alberts, David S., Barakat, Richard R.

“…To evaluate the incidence and risk factors for lymphedema associated with surgery for gynecologic malignancies on GOG study 244. Women undergoing a lymph node…”
Get full text

Evaluation of physical function and quality of life before and after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2–IB1 cervical cancer (GOG-278) by Covens, Allan, Huang, Helen, Kim, Yong-Beom, Kim, Moon-Hong, Stuckey, Ashley, Vicus, Danielle, Holman, Laura, Fleury, Aimee, Pearson, Joseph, Thawani, Niticka, Shahin, Mark, Lea, Jayanthi, Robertson, Sharon, Warshal, David, Backes, Floor, Feltmate, Colleen, Wilkinson-Ryan, Ivy, Carter, Jeanne

Get full text

A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer by Rimel, B.J., Bender, David, Enserro, Danielle, Westin, Shannon Neville, Richardson, Debra L., Holman, Laura L., Alluri, Nitya, Stuckey, Ashley, Garg, Ruchi, Gill, Sarah, Tanner, Edward, Leath, Charles A., Backes, Floor Jenniskens, Fleury, Aimee, Mackay, Helen

“…TPS5629 Background: Identifying new approaches for the treatment of advanced endometrial cancer (EC) is a priority. A platform study design allows for a faster…”
Get full text

Evaluation of efficacy and fertility after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2–IB1 (GOG-278) cervical cancer by Covens, Allan, Huang, Helen, Kim, Yong-Beom, Kim, Moon-Hong, DiSilvestro, Paul, Vicus, Danielle, Holman, Laura, Fleury, Aimee, Pearson, Joseph, Thawani, Nitika, Shahin, Mark, Lea, Jayanthi, Robertson, Sharon, Warshal, David, Backes, Floor, Feltmate, Colleen, Dewdney, Summer, Leitao, Mario, Wilkinson-Ryan, Ivy, Elsayed, Ahmed, Carter, Jeanne

Get full text

Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012 by Mackay, Helen, Nixon, Andrew B., Enserro, Danielle, Bender, David, Rimel, BJ, Powell, Matthew A., Richardson, Debra L., Holman, Laura L., Alluri, Nitya, Mathews, Cara Amanda, Garg, Ruchi, Gill, Sarah, Matei, Daniela, Leath, Charles A., Backes, Floor Jenniskens, Fleury, Aimee, Swisher, Elizabeth M.

“…5525 Background: NRG GY012 is a randomized, 3-arm phase II study, comparing olaparib (O) and the combination of cediranib and olaparib (CO) to the reference…”
Get full text

Vulvar basal cell carcinoma in a 20-year-old: Case report and review of the literature by Fleury, Aimee C, Junkins-Hopkins, Jacqueline M, Diaz-Montes, Teresa

“…Highlights ► Vulvar basal cell carcinoma is a rare tumor. ► This report highlights the presentation of vulvar basal cell carcinoma in a very young, non-White…”
Get full text

Secondary Debulking Including Nephrectomy in Recurrent Uterine Carcinosarcoma: A Case Report by Kushnir, Christina L, Fleury, Aimee C, Futoran, Robert J, Spirtos, Nick M

“…Abstract The role of secondary cytoreduction in the treatment of recurrent uterine carcinosarcoma is controversial. This report explores the effectiveness of…”
Get full text

The Use of Radiofrequency Ablation in Advanced Ovarian Cancer: Resection and Ablation of Liver Metastases by Fleury, Aimee C, Spirtos, Nick M, Eisenkop, Scott M, Kirgan, Daniel M, Silver, David F, Futoran, Robert J

“…Abstract Metastases to liver parenchyma pose a challenge to cytoreductive efforts because of the high rates of morbidity and mortality associated with liver…”
Get full text

Abnormal Cervical Cytology in the Diagnosis of Uterine Papillary Serous Carcinoma: Earlier Detection of a Poor Prognostic Cancer Subtype by Skaznik-Wikiel, Malgorzata E., Ueda, Stefanie M., Frasure, Heidi E., Rose, Peter G., Fleury, Aimee, Grumbine, Francis C., Fader, Amanda Nickles

“…Objective: Early detection of uterine papillary serous (UPSC), clear cell (CCC), and grade 3 endometrioid carcinomas (G3EC) – all poor prognostic variants of…”
Get full text